LRRC15影响A549细胞自噬的作用研究
收稿日期: 2024-01-07
修回日期: 2024-03-04
网络出版日期: 2024-03-12
基金资助
河南省高等学校重点科研项目计划(22A180018);河南省科技攻关项目(232102310067);国家肺纤维化生物学学科创新引智基地(“jl0”计划)
Effect of LRRC15 on autophagy in A549 cells
Received date: 2024-01-07
Revised date: 2024-03-04
Online published: 2024-03-12
Supported by
Key Scientific Research Projects of Henan Higher Education(22A180018);Henan Project of Science and Technology(232102310067);State Innovation Base for Pulmonary Fibrosis(“jl0”计划)
特发性肺纤维化(idiopathic pulmonary fibrosis，IPF)是一种致病原因不明、进行性、慢性不可逆的间质性肺疾病。为探讨富含亮氨酸重复蛋白15(leucine-rich repeat-containing protein 15，LRRC15)在IPF的作用及调节机制，本研究构建了博来霉素(bleomycin，BLM)诱导的小鼠肺纤维化和A549细胞损伤模型，检测了LRRC15的表达变化。转染siLRRC15后分别采用MTT、GFP-RFP-LC3双荧光标记系统和免疫印迹等方法检测了细胞活性和自噬的变化。结果表明：BLM处理后，小鼠肺组织和A549细胞中LRRC15表达显著上调；将设计和合成的siLRRC15转入A549细胞，LRRC15的表达极显著降低，可以部分恢复BLM引起的细胞损伤；BLM处理A549细胞后，LC3-II和P62蛋白呈现上升的趋势；GFP-RFP-LC3双荧光标记检测发现，BLM处理后自噬体数量明显增多；进一步用siLRRC15处理A549细胞后发现，自噬关键蛋白LC3-II、ATG5、ATG7的表达增加，P62蛋白表达下调，自噬流的强度增加。以上研究结果说明LRRC15是IPF中上皮细胞损伤的指示剂，可能通过调节自噬参与纤维化过程中的调节，本研究为进一步阐明IPF的机制提供了必要的理论依据。
王棋文, 贾燕玲, 李盼, 余国营 . LRRC15影响A549细胞自噬的作用研究[J]. 遗传, 2024 , 46(5) : 398 -407 . DOI: 10.16288/j.yczz.23-299
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic, and irreversible interstitial lung disease with unknown cause. To explore the role and regulatory mechanism of leucine-rich repeat-containing protein 15 (LRRC15) in IPF, bleomycin (BLM)-induced pulmonary fibrosis in mouse and A549 cells were constructed, and the expression of LRRC15 were detected. Then, MTT, GFP-RFP-LC3 dual fluorescent labeling system and Western blotting were used to investigate the effects of LRRC15 on cell activity and autophagy after transfection of siLRRC15, respectively. The results indicated that the expression of LRRC15 was significantly increased after the BLM treatment in mouse lung tissue and A549 cells. The designed and synthesized siLRRC15 followed by transfection into A549 cells resulted in a dramatic reduction in LRRC15 expression and partially restored the cell damage induced by BLM. Moreover, the expression of LC3-II and P62 were up-regulated, the amount of autophagosome were increased by GFP-RFP-LC3 dual fluorescent labeling assay after BLM treatment. Meanwhile, this study also showed that the key autophagy proteins LC3-II, ATG5 and ATG7 were up-regulated, P62 was down-regulated and autophagic flux were enhanced after further treatment of A549 cells with siLRRC15. The above findings suggest that LRRC15 is an indicator of epithelial cell damage and may participate in the regulation of fibrosis through autophagy mechanism in IPF. This study provides necessary theoretical basis for further elucidating the mechanism of IPF.
Key words： LRRC15; idiopathic pulmonary fibrosis; bleomycin; A549 cells; autophagy
| [1] | Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med, 2018, 378(19): 1811-1823. |
| [2] | Miao Y, Li XH, Zhan YQ, Bai JK, Ma XY, Xi BR, Zhang JW, Zhou HG, Yang C. Research and development progress of antibody drugs for idiopathic pulmonary fibrosis. Acta Pharm Sin, 2021, 56(11): 2881-2886. |
| 苗洋, 李霄鹤, 翟芸芊, 白佳坤, 马晓阳, 希布日, 张建伟, 周红刚, 杨诚. 特发性肺纤维化抗体药物研发进展. 药学学报, 2021, 56(11): 2881-2886. | |
| [3] | Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet, 2017, 389(10082): 1941-1952. |
| [4] | Mi S, Li Z, Yang HZ, Liu H, Wang JP, Ma YG, Wang XX, Liu HZ, Sun W, Hu ZW. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-β1-dependent and -independent mechanisms. J Immunol, 2011, 187(6): 3003-3014. |
| [5] | Margaritopoulos GA, Tsitoura E, Tzanakis N, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM. Self-eating: friend or foe? The emerging role of autophagy in idiopathic pulmonary fibrosis. Biomed Res Int, 2013, 2013: 420497. |
| [6] | Ray U, Pathoulas CL, Thirusangu P, Purcell JW, Kannan N, Shridhar V. Exploiting LRRC 15 as a novel therapeutic target in cancer. Cancer Res, 2022, 82(9): 1675-1681. |
| [7] | O'Prey J, Wilkinson S, Ryan KM. Tumor antigen LRRC15 impedes adenoviral infection: implications for virus-based cancer therapy. J Virol, 2008, 82(12): 5933-5939. |
| [8] | Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T, Kumar S, Samayoa J, Zhang D, Palma JP, Mishra S, Hollenbaugh D, Gish K, Morgan-Lappe SE, Hsi ED, Chao DT. LRRC 15 Is a novel mesenchymal protein and stromal target for antibody-drug conjugates. Cancer Res, 2018, 78(14): 4059-4072. |
| [9] | Mariani A, Wang C, Oberg AL, Riska SM, Torres M, Kumka J, Multinu F, Sagar G, Roy D, Jung DB, Zhang Q, Grassi T, Visscher DW, Patel VP, Jin L, Staub JK, Cliby WA, Weroha SJ, Kalli KR, Hartmann LC, Kaufmann SH, Goode EL, Shridhar V. Genes associated with bowel metastases in ovarian cancer. Gynecol Oncol, 2019, 154(3): 495-504. |
| [10] | Sul OJ, Kim JH, Lee T, Seo KW, Cha HJ, Kwon B, Ahn JJ, Cho YS, Oh YM, Jegal Y, Ra SW. GSPE protects against bleomycin-induced pulmonary fibrosis in mice via ameliorating epithelial apoptosis through inhibition of oxidative stress. Oxid Med Cell Longev, 2022, 2022: 8200189. |
| [11] | Li L, Wang YY, Cheng MQ, Yin JB, Zhang X, Li L. Inhibitory effect of gentiopicroside on the apoptosis of alveolar epithelial cells induced by bleomycin. J Kunming Med Univ, 2019, 40(6): 11-15. |
| 李莉, 王永艳, 成梦群, 尹健彬, 张旋, 李丽. 龙胆苦苷对博来霉素诱导肺泡上皮细胞凋亡的抑制作用. 昆明医科大学学报, 2019, 40(6): 11-15. | |
| [12] | Thannickal VJ, Toews GB, White ES, Lynch JP 3rd, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med, 2004, 55: 395-417. |
| [13] | Zhang L, Wang Y, Wu GR, Xiong WN, Gu WK, Wang CY. Macrophages: friend or foe in idiopathic pulmonary fibrosis? Respir Res, 2018, 19(1): 170. |
| [14] | Dominguez CX, Müller S, Keerthivasan S, Koeppen H, Hung J, Gierke S, Breart B, Foreman O, Bainbridge TW, Castiglioni A, Senbabaoglu Y, Modrusan Z, Liang YX, Junttila MR, Klijn C, Bourgon R, Turley SJ. Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov, 2020, 10(2): 232-253. |
| [15] | Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res, 2006, 66(10): 5278-5286. |
| [16] | Kimura S, Fujita N, Noda T, Yoshimori T.Monitoring autophagy in mammalian cultured cells through the dynamics of LC3. Methods Enzymol, 2009, 452: 1-12. |
| [17] | BenYounès A, Tajeddine N, Tailler M, Malik SA, Shen SS, Métivier D, Kepp O, Vitale I, Maiuri MC, Kroemer G.A fluorescence-microscopic and cytofluorometric system for monitoring the turnover of the autophagic substrate p62/SQSTM1. Autophagy, 2011, 7(8): 883-891. |
| [18] | Lu JL, Yu CX, Song LJ. Programmed cell death in hepatic fibrosis: current and perspectives. Cell Death Discov, 2023, 9(1): 449. |
| [19] | Wen JH, Li DY, Liang S, Yang C, Tang JX, Liu HF. Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis. Front Immunol, 2022, 13: 946832. |
| [20] | Wang QW, Chang CF, Gu NN, Pan CY, Xu CS. Effect of autophagy on liver regeneration. Hereditas (Beijing), 2015, 37(11): 1116-1124. |
| 王棋文, 常翠芳, 谷宁宁, 潘翠云, 徐存拴. 自噬在肝再生中的作用. 遗传, 2015, 37(11): 1116-1124. | |
| [21] | Araya J, Kojima J, Takasaka N, Ito S, Fujii S, Hara H, Yanagisawa H, Kobayashi K, Tsurushige C, Kawaishi M, Kamiya N, Hirano J, Odaka M, Morikawa T, Nishimura SL, Kawabata Y, Hano H, Nakayama K, Kuwano K. Insufficient autophagy in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 2013, 304(1): L56-69. |
| [22] | Cabrera S, Maciel M, Herrera I, Nava T, Vergara F, Gaxiola M, López-Otín C, Selman M, Pardo A. Essential role for the ATG4B protease and autophagy in bleomycin- induced pulmonary fibrosis. Autophagy, 2015, 11(4): 670-684. |
| [23] | Kobayashi K, Araya J, Minagawa S, Hara H, Saito N, Kadota T, Sato N, Yoshida M, Tsubouchi K, Kurita Y, Ito S, Fujita Y, Takasaka N, Utsumi H, Yanagisawa H, Hashimoto M, Wakui H, Kojima J, Shimizu K, Numata T, Kawaishi M, Kaneko Y, Asano H, Yamashita M, Odaka M, Morikawa T, Nakayama K, Kuwano K. Involvement of PARK2-mediated mitophagy in idiopathic pulmonary fibrosis pathogenesis. J Immunol, 2016, 197(2): 504-516. |
| [24] | Sosulski ML, Gongora R, Danchuk S, Dong CM, Luo FY, Sanchez CG.Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1. Aging Cell, 2015, 14(5): 774-783. |
| [25] | Yu GY, Tzouvelekis A, Wang R, Herazo-Maya JD, Ibarra GH, Srivastava A, DeIuliis G, Ahangari F, Woolard T, Aurelien N, Arrojo E Drigo R, Gan Y, Graham M, Liu XR, Homer RJ, Scanlan TS, Mannam P, Lee PJ, Herzog EL, Bianco AC, Kaminski N. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nat Med, 2017, 24(1): 39-49. |
| [26] | Gui XH, Chen HW, Cai HR, Sun LY, Gu L. Leptin promotes pulmonary fibrosis development by inhibiting autophagy via PI3K/Akt/mTOR pathway. Biochem Biophys Res Commun, 2018, 498(3): 660-666. |
| [27] | Xu G, Wang X, Yu H, Wang C, Liu Y, Zhao R, Zhang G. Beclin 1, LC3, and p62 expression in paraquat-induced pulmonary fibrosis. Hum Exp Toxicol, 2019, 38(7): 794-802. |
| [28] | Zhao XY, Wei SS, Li ZJ, Lin C, Zhu ZF, Sun DS, Bai RP, Qian J, Gao XW, Chen GD, Xu ZP. Autophagic flux blockage in alveolar epithelial cells is essential in silica nanoparticle-induced pulmonary fibrosis. Cell Death Dis, 2019, 10(2): 127. |
| [29] | Wang YJ, Liu YS, Zhang M, Lv LW, Zhang X, Zhang P, Zhou YS. LRRC 15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/ nuclear translocation. Stem Cell Res Ther, 2018, 9(1): 65. |
/
| 〈 |
|
〉 |
www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:
